High-Dose Inactivated Influenza Vaccine can Reduce Costs and Improve Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors

Autor:	Michael Drummond, Ayman Chit, Eddy Yau, Debbie L. Becker, Carlos A. DiazGranados, M. Maschio
Rok vydání:	2015
Předmět:	business.industry Influenza vaccine Health Policy Public Health Environmental and Occupational Health Medicine Live attenuated influenza vaccine business Virology
Zdroj:	Value in Health. 18(7):A587-A588
ISSN:	1098-3015
DOI:	10.1016/j.jval.2015.09.1502
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69edcc3d0cc0af16fdd75a795dad92a Zobrazit plný text záznamu Full Text from ScienceDirect